[ad_1]
DUBLIN, Oct. 11, 2022 /PRNewswire/ — The “Pharmaceutical Drug Delivery Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.
The global pharmaceutical drug delivery market is expected to grow from $1510.17 billion in 2021 to $1591.81 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The pharmaceutical drug delivery market is expected to grow to $1920.96 billion in 2026 at a CAGR of 4.8%.
North America was the largest region in the pharmaceutical drug delivery market in 2021. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this pharmaceutical drug delivery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The growing prevalence of chronic diseases is expected to propel the growth of the pharmaceutical drug delivery market going forward. Prevalence of chronic diseases refers to the total number of existing cases of chronic diseases in a population at a specific time. Pharmaceutical drug delivery helps the patients suffering from chronic diseases by delivering a pharmaceutical drug to a specific part of the body to treat different diseases.
For instance, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, noncommunicable diseases kill 41 million people each year, equivalent to 71% of all deaths globally and cardiovascular diseases account for most of the deaths. Therefore, the growing prevalence of chronic diseases is driving the pharmaceutical drug delivery market.
The…
Full story available on Benzinga.com
[ad_2]
Source link
